Moreover, we identified a novel relapse-specific gene signature specific for DUX4BCP-ALL patients highlighting chemotaxis and cytokine environment as a possible driver event at relapse.
DUX4 plays critical role in the molecular pathogenesis of the neuromuscular disorder facioscapulohumeral muscular dystrophy and acute lymphoblastic leukemia in humans.